IPP Bureau
Zydus’s acquisition of Assertio to bolster its specialty pharma presence in US market
By IPP Bureau - June 20, 2026
Upon completion of the merger, Assertio will become a wholly owned subsidiary of Zydus Lifesciences and will be delisted from the Nasdaq
Alembic Pharma receives USFDA tentative approval for Binimetinib tablets
By IPP Bureau - June 20, 2026
Company becomes sole first applicant for 45 mg strength, positioning itself for potential 180-day generic exclusivity in the US market
Manipal Hospitals Mukundapur launches advanced Neuro Biplane Cathlab
By IPP Bureau - June 20, 2026
State-of-the-art facility brings next-generation imaging and minimally invasive neurointerventional capabilities to Eastern India
Automated cell therapy manufacturing attracts US$1.1 Billion across 34 funding rounds
By IPP Bureau - June 20, 2026
New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
Quadria-backed HealthQuad closes Rs. 550 crore first close for fund 3
By IPP Bureau - June 20, 2026
Backs Lifesigns in first bet and doubles down on India’s healthcare AI surge
Govt pushes for identifying every missing TB case
By IPP Bureau - June 20, 2026
Over 28 crore people screened, TB incidence falls sharply as Centre urges states to intensify efforts ahead of July campaign deadline
AngioDynamics gets FDA nod for RELIEF trial to evaluate NanoKnife for enlarged prostate treatment
By IPP Bureau - June 19, 2026
Study will assess the safety and effectiveness of irreversible electroporation as a minimally invasive treatment option for benign prostatic hyperplasia (BPH)
Apollo Hospitals Seshadripuram expands cardiac care capacity with second Cath Lab
By IPP Bureau - June 19, 2026
New facility equipped with advanced imaging technology to support 200 additional procedures a month and benefit nearly 3,000 more patients annually
Brooks Instrument launches ultra-compact advanced mass flow controller for research applications
By IPP Bureau - June 19, 2026
New AMF Series combines industry-leading 1000:1 turndown capability, predictive diagnostics, and digital connectivity in a footprint no larger than a standard Post-it Note pad
Tata Cancer Care Foundation launches Voice of Courage podcast
By IPP Bureau - June 19, 2026
Developed with Wondrlab India, the 10-episode series brings together healthcare experts, a cancer survivor, and filmmaker Amole Gupte to foster meaningful conversations
J.P. Nadda reviews dengue and malaria preparedness across India
By IPP Bureau - June 19, 2026
Union Health Minister calls for heightened vigilance, stronger public awareness campaigns, and district-specific action plans for the high-transmission season
Dr. Gullapalli N. Rao conferred SantokBaa Humanitarian Award 2026
By IPP Bureau - June 19, 2026
LV Prasad Eye Institute founder recognized for his pioneering contribution to affordable and accessible eye care; award celebrates two decades of honoring transformative humanitarian leadership.
Biopharma industry confidence reaches four-year high: GlobalData survey
By IPP Bureau - June 19, 2026
Findings show growing optimism across the pharma sector as dealmaking accelerates, innovation strengthens, and companies adapt to tariffs, pricing reforms, and looming patent expirations
Cipla Health elevates Kunal Mehta to Associate Director – Marketing
By IPP Bureau - June 19, 2026
Marketing leader behind growth of brands such as Cipladine, Maxirich, and Soak Shield takes on expanded responsibilities to drive portfolio growth and consumer engagement.
Moderna reshapes leadership and ops model as it pushes into oncology, rare disease
By IPP Bureau - June 18, 2026
CEO Stéphane Bancel framed the changes as essential to scaling the business
